UniSuper Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,900
Closed -$334K 695
2024
Q3
$334K Buy
+4,900
New +$277K ﹤0.01% 684
2024
Q2
Sell
-2,600
Closed -$180K 978
2024
Q1
$180K Buy
2,600
+1,300
+100% +$82.2K ﹤0.01% 942
2023
Q4
$96.2K Hold
1,300
﹤0.01% 655
2023
Q3
$88.7K Hold
1,300
﹤0.01% 613
2023
Q2
$122K Buy
+1,300
New +$101K ﹤0.01% 546

Other funds holding EXAS

UniSuper Management's EXAS Position: Q4 2024 in Review

UniSuper Management sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 4,900 shares — an estimated $334K sold.

UniSuper Management first reported a position in EXAS in Q2 2023 and held it in 5 quarters. The position peaked at $334K in Q3 2024. 593 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • UniSuper Management reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • UniSuper Management sold 4,900 Exact Sciences shares in Q4 2024, an estimated $334K.
  • UniSuper Management first reported a position in Exact Sciences in Q2 2023 and held it in 5 quarters.
  • UniSuper Management's Exact Sciences position peaked at $334K in Q3 2024.
  • 593 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on UniSuper Management's 13F filing for Q4 2024, filed 12 Feb 2025.